Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-030681
Filing Date
2016-05-04
Accepted
2016-05-04 07:32:33
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20160331_10q.htm 10-Q 813446
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 57359
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 51901
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 15362
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 15321
6 EXHIBIT 32 ex32.htm EX-32 8283
  Complete submission text file 0001437749-16-030681.txt   2824255

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS oxfd-20160331.xml EX-101.INS 346713
8 EXHIBIT 101.SCH oxfd-20160331.xsd EX-101.SCH 29945
9 EXHIBIT 101.CAL oxfd-20160331_cal.xml EX-101.CAL 37619
10 EXHIBIT 101.DEF oxfd-20160331_def.xml EX-101.DEF 193119
11 EXHIBIT 101.LAB oxfd-20160331_lab.xml EX-101.LAB 177695
12 EXHIBIT 101.PRE oxfd-20160331_pre.xml EX-101.PRE 207724
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 161617408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances